Back to results

Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment

Primary Purpose

Substance-Related Disorders, Treatment Adherence

Status

Recruiting

Phase

Not Applicable

Locations

United States

Study Type

Interventional

Intervention

Motivational Interviewing at Intake (MII)

Intake as Usual (IAU)

About this trial

This is an interventional health services research trial for Substance-Related Disorders

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria (client participants):

English-speaking adults seeking treatment for alcohol or other drug use at one of two outpatient addiction treatment programs
Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures
Physically withdrawn from alcohol or other drugs

Inclusion Criteria (personnel participants):

English-speaking adults currently employed at one of the two outpatient addiction treatment programs
Provision of electronic informed consent

Exclusion Criteria (client participants):

Experiencing severe withdrawal symptoms
Actively psychotic, manic, and/or suicidal

Exclusion Criteria (personnel participants):

current position: facility owner or clinical director

Sites / Locations

Turning Point Recovery CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Motivational Interviewing at Intake (MII)

Intake as Usual (IAU)

Arm Description

Clients allocated to the MII condition will receive a 90-minute pure Motivational Interviewing (MI) session.

Clients allocated to the IAU condition will receive the 90-minute standard assessment that is delivered to all clients entering intensive outpatient program (IOP)/outpatient program (OP).

Outcomes

Primary Outcome Measures

Number of participants who attended the first outpatient treatment program session based on electronic medical record review

Treatment entry is determined by review of electronic medical record of whether clients attended their first scheduled treatment session

Number of treatment sessions attended during the three-month outpatient treatment program based on electronic medical record review

Number of treatment sessions that clients attend is determined by review of electronic medical record and calculating number of treatment sessions attended.

Number of participants who completed the three-month outpatient treatment program based on electronic medical record review

Completion of the three-month outpatient treatment program is determined by review of electronic medical record

Secondary Outcome Measures

Change from baseline in client readiness to enter treatment on the University of Rhode Island Change Assessment Scale (URICA) at 1 hour post-intake

The URICA is a validated, self-report measure of client readiness for treatment engagement. Possible scores range from 32 to 160 with higher scores indicative greater readiness to enter treatment. Change = (Hour 1 score - Baseline Score).

Score on therapeutic alliance on the Working Alliance Inventory (WAI) at 1-hour post-intake

The WAI is a validated, self-report measure of client perceptions of the therapeutic process by assessing three sub scales: Goals, Bond, and Tasks. Possible scores on sub scales range from 12 to 84 with higher scores indicative of better therapeutic alliance.

Full Information

NCT ID

NCT05489068

First Posted

July 26, 2022

Last Updated

May 8, 2023

Sponsor

University of New Mexico

Collaborators

National Institute on Drug Abuse (NIDA)

1. Study Identification

Unique Protocol Identification Number

NCT05489068

Brief Title

Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment

Official Title

Adapting Intake Procedures to Improve Treatment Delivery in Addiction Treatment

Study Type

Interventional

2. Study Status

Record Verification Date

May 2023

Overall Recruitment Status

Recruiting

Study Start Date

March 16, 2022 (Actual)

Primary Completion Date

October 2024 (Anticipated)

Study Completion Date

December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title

Sponsor

Name of the Sponsor

University of New Mexico

Collaborators

National Institute on Drug Abuse (NIDA)

4. Oversight

Studies a U.S. FDA-regulated Drug Product

Studies a U.S. FDA-regulated Device Product

Data Monitoring Committee

Yes

5. Study Description

Brief Summary

This K23 study is an effectiveness-implementation hybrid type I design to determine the effectiveness of Motivational Interviewing at Intake (MII), relative to intake-as-usual on client engagement and mechanisms of engagement among adults seeking outpatient addiction treatment. We also will obtain personnel feedback on the feasibility of implementing MII into standard practice by having personnel from the addiction treatment study sites complete implementation climate measures before Motivational Interviewing (MI) training and post-clinical trial, as well as an individual interview on implementation feasibility post-trial.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Substance-Related Disorders, Treatment Adherence

7. Study Design

Primary Purpose

Health Services Research

Study Phase

Not Applicable

Interventional Study Model

Parallel Assignment

Model Description

Effectiveness-Implementation Hybrid Type 1 Design

Masking

ParticipantInvestigatorOutcomes Assessor

Allocation

Randomized

Enrollment

150 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title

Motivational Interviewing at Intake (MII)

Arm Type

Experimental

Arm Description

Clients allocated to the MII condition will receive a 90-minute pure Motivational Interviewing (MI) session.

Arm Title

Intake as Usual (IAU)

Arm Type

Active Comparator

Arm Description

Clients allocated to the IAU condition will receive the 90-minute standard assessment that is delivered to all clients entering intensive outpatient program (IOP)/outpatient program (OP).

Intervention Type

Behavioral

Intervention Name(s)

Motivational Interviewing at Intake (MII)

Intervention Description

The MII will involve a goal-oriented and collaborative conversation about why the client wants treatment now, and how treatment might fit with his/her most important values. The provider will use open questions, reflective listening and autonomy support in a flexible, non-authoritative manner. Rather than asking specific questions in different life domains, the provider will explore with the client their desires, abilities, reasons, and needs for treatment, how treatment fits with their values, and what successful treatment looks like to them. The client's language about change will be strategically reinforced to increase its frequency and strength across the session.

Intervention Type

Behavioral

Intervention Name(s)

Intake as Usual (IAU)

Intervention Description

In line with the American Society of Addiction Medicine (ASAM) guidelines, the IAU condition involves a semi-structured interview of the client's psychosocial history and clients answer a series of questions in the following domains: support system, living situation, educational, occupational, family, and medical history.

Primary Outcome Measure Information:

Title

Number of participants who attended the first outpatient treatment program session based on electronic medical record review

Description

Treatment entry is determined by review of electronic medical record of whether clients attended their first scheduled treatment session

Time Frame

up to 36 weeks

Title

Number of treatment sessions attended during the three-month outpatient treatment program based on electronic medical record review

Description

Number of treatment sessions that clients attend is determined by review of electronic medical record and calculating number of treatment sessions attended.

Time Frame

up to 36 weeks

Title

Number of participants who completed the three-month outpatient treatment program based on electronic medical record review

Description

Completion of the three-month outpatient treatment program is determined by review of electronic medical record

Time Frame

up to 36 weeks

Secondary Outcome Measure Information:

Title

Change from baseline in client readiness to enter treatment on the University of Rhode Island Change Assessment Scale (URICA) at 1 hour post-intake

Description

Time Frame

baseline and 1 hour post-intake

Title

Score on therapeutic alliance on the Working Alliance Inventory (WAI) at 1-hour post-intake

Description

Time Frame

1 hour post-intake

Other Pre-specified Outcome Measures:

Title

Change from baseline in organizational readiness to change on the Texas Christian University-Organizational Readiness to Change (TCU-ORC) at 1 year

Description

The TCU-ORC is a validated, self-report measure of personnel perceptions of their organization's readiness and willingness to make changes. Possible scores range from 125 to 625 with higher scores indicative of more readiness to change. Change = (Year 1 score - Baseline Score).

Time Frame

baseline and 1 year

Title

Change from baseline in organizational readiness to change on the Readiness for Organizational Change (ROC) at 1 year

Description

The ROC is a validated, self-report measure of personnel perceptions of their organization's readiness to change. Possible scores range from 25 to 155 with higher scores indicative of more readiness to change. Change = (Year 1 score - Baseline Score).

Time Frame

baseline and 1 year

Title

Change from baseline in organizational capability to change on the Change Process Capability Questionnaire (CPCQ) at Year 1

Description

The CPCQ is a validated, self-report measure of personnel perceptions of of their organization's capability to change. Possible scores range from 1 to 132 with higher scores indicative of more capability to make changes in the organization. Change = (Year 1 score - Baseline Score).

Time Frame

baseline and 1 year

10. Eligibility

Sex

All

Minimum Age & Unit of Time

18 Years

Accepts Healthy Volunteers

Eligibility Criteria

Inclusion Criteria (client participants): English-speaking adults seeking treatment for alcohol or other drug use at one of two outpatient addiction treatment programs Provision of signed and dated informed consent form Stated willingness to comply with all study procedures Physically withdrawn from alcohol or other drugs Inclusion Criteria (personnel participants): English-speaking adults currently employed at one of the two outpatient addiction treatment programs Provision of electronic informed consent Exclusion Criteria (client participants): Experiencing severe withdrawal symptoms Actively psychotic, manic, and/or suicidal Exclusion Criteria (personnel participants): current position: facility owner or clinical director

Central Contact Person:

First Name & Middle Initial & Last Name or Official Title & Degree

Margo Hurlocker, PhD

Phone

(505) 596-0578

mhurlocker@unm.edu

Overall Study Officials:

First Name & Middle Initial & Last Name & Degree

Margo Hurlocker, PhD

Organizational Affiliation

University of New Mexico

Official's Role

Principal Investigator

Facility Information:

Facility Name

Turning Point Recovery Center

City

Albuquerque

State/Province

New Mexico

ZIP/Postal Code

87111

Country

United States

Individual Site Status

Recruiting

Facility Contact:

First Name & Middle Initial & Last Name & Degree

Alaina Geoff

Phone

505-217-1717

alaina@turningpointrc.com

12. IPD Sharing Statement

Plan to Share IPD

Yes

IPD Sharing Plan Description

Individual participant data that underlie results reported in a peer-reviewed publication, after deidentification (text, tables, figures, and appendices). Session audio recordings will not be shared.

IPD Sharing Time Frame

Data will become available starting in January 2025

IPD Sharing Access Criteria

Researchers who provide a methodologically sound proposal will have access to the data. A data use agreement will be required, signed by the requesting investigator and their Authorized Organization Representation (AOR)/Signing Official (SO)

Learn more about this trial

Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment

We'll reach out to this number within 24 hrs